Brainsway (BRSYF) Short term Debt (2018)

Brainsway posted quarterly Short term Debt of $750000.0 for Q4 2018.

Brainsway (BRSYF) has 1 years of Short term Debt data on file, last reported at $750000.0 in Q4 2018.

  • For the quarter ending Q4 2018, Short term Debt changed N/A year-over-year to $750000.0; the trailing twelve-month figure through Dec 2018 stood at $750000.0 (changed N/A YoY), and the FY2018 full-year result was $750000.0, changed N/A from the prior year.
  • Short term Debt for Q4 2018 stood at $750000.0.
  • Across five years, Short term Debt topped out at $750000.0 in Q4 2018 and bottomed at $750000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Brainsway - - 11.68 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 750,000.00